Skip to main content
SpringerLink
Log in

Alendronic acid/denosumab/ibandronic acid

Stage 2 medication-related osteonecrosis of the jaw: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pardo-Zamora G, et al. Treatment of stage 2 medication-induced osteonecrosis of the jaw: A case series. International Journal of Environmental Research and Public Health 18: 1-18, No. 3, Feb 2021. Available from: URL: http://doi.org/10.3390/ijerph18031018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alendronic acid/denosumab/ibandronic acid. Reactions Weekly 1846, 20 (2021). https://doi.org/10.1007/s40278-021-92268-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92268-9

Search

Navigation